Loading candles…
Biofil Chemicals and Pharmaceuticals Ltd, incorporated in 1993, is headquartered in Indore, Madhya Pradesh, India. The company operates in the pharmaceutical and chemical manufacturing industries. It produces pharmaceutical bulk drugs and pharmaceutical formulations, as well as chemical products. Biofil Chemicals and Pharmaceuticals functions through two main business segments: the Pharma Division and the Chemicals Division. Its operations primarily serve the healthcare sector within India. There are no publicly disclosed details about founders, key management, subsidiaries, or listings on stock exchanges.
This page is a live market overview for BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) on the NSE. As a listed security, BIOFIL CHEM & PHARMA LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BIOFILCHEM before placing trades on tick2trade.
As of the latest feed, BIOFILCHEM last traded at ₹32.39 on NSE, up ₹0.16 (0.50%) from the previous close of ₹32.23. Today's session range is ₹31.32 – ₹33.5, against a 52-week band of ₹25.6 – ₹46.34. Traded volume today stands at 5.40K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for BIOFILCHEM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BIOFILCHEM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BIOFIL CHEM & PHARMA LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BIOFILCHEM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BIOFILCHEM option chain page linked from this overview.
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 30 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.